Literature DB >> 29685683

Design, solid-phase synthesis and evaluation of enterobactin analogs for iron delivery into the human pathogen Campylobacter jejuni.

Cristina Y Zamora1, Amaël G E Madec1, Wilma Neumann2, Elizabeth M Nolan2, Barbara Imperiali3.   

Abstract

The human enteropathogen Campylobacter jejuni, like many bacteria, employs siderophores such as enterobactin for cellular uptake of ferric iron. This transport process has been shown to be essential for virulence and presents an attractive opportunity for further study of the permissiveness of this pathway to small-molecule intervention and as inspiration for the development of synthetic carriers that may effectively transport cargo into Gram-negative bacteria. In this work, we have developed a facile and robust microscale assay to measure growth recovery of C. jejuni NCTC 11168 in liquid culture as a result of ferric iron uptake. In parallel, we have established the solid-phase synthesis of catecholamide compounds modeled on enterobactin fragments. Applying these methodological developments, we show that small synthetic iron chelators of minimal dimensions provide ferric iron to C. jejuni with equal or greater efficiency than enterobactin.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Campylobacter jejuni NCTC 11168; CeuBCDE; CfrA; Enterobactin; Gram-negative pathogens; Iron acquisition; Siderophore; Solid-phase synthesis

Mesh:

Substances:

Year:  2018        PMID: 29685683      PMCID: PMC6191362          DOI: 10.1016/j.bmc.2018.04.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  25 in total

Review 1.  Antibacterial drug discovery in the resistance era.

Authors:  Eric D Brown; Gerard D Wright
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

2.  An [{Fe(mecam)}2]6- bridge in the crystal structure of a ferric enterobactin binding protein.

Authors:  Axel Müller; Anthony J Wilkinson; Keith S Wilson; Anne-K Duhme-Klair
Journal:  Angew Chem Int Ed Engl       Date:  2006-08-04       Impact factor: 15.336

Review 3.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

4.  Identification and characterization of a periplasmic trilactone esterase, Cee, revealed unique features of ferric enterobactin acquisition in Campylobacter.

Authors:  Ximin Zeng; Yiming Mo; Fuzhou Xu; Jun Lin
Journal:  Mol Microbiol       Date:  2012-12-19       Impact factor: 3.501

5.  Siderophore-mediated cargo delivery to the cytoplasm of Escherichia coli and Pseudomonas aeruginosa: syntheses of monofunctionalized enterobactin scaffolds and evaluation of enterobactin-cargo conjugate uptake.

Authors:  Tengfei Zheng; Justin L Bullock; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2012-10-25       Impact factor: 15.419

Review 6.  Pumping iron: mechanisms for iron uptake by Campylobacter.

Authors:  Claire E Miller; Peter H Williams; Julian M Ketley
Journal:  Microbiology       Date:  2009-08-20       Impact factor: 2.777

7.  Campylobacter jejuni ferric-enterobactin receptor CfrA is TonB3 dependent and mediates iron acquisition from structurally different catechol siderophores.

Authors:  Hemant Naikare; James Butcher; Annika Flint; Jide Xu; Kenneth N Raymond; Alain Stintzi
Journal:  Metallomics       Date:  2013-08       Impact factor: 4.526

8.  Iron acquisition and regulation in Campylobacter jejuni.

Authors:  Kiran Palyada; Deborah Threadgill; Alain Stintzi
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

9.  Enzymatic hydrolysis of trilactone siderophores: where chiral recognition occurs in enterobactin and bacillibactin iron transport.

Authors:  Rebecca J Abergel; Anna M Zawadzka; Trisha M Hoette; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2009-09-09       Impact factor: 15.419

Review 10.  Nutrient acquisition and metabolism by Campylobacter jejuni.

Authors:  Martin Stahl; James Butcher; Alain Stintzi
Journal:  Front Cell Infect Microbiol       Date:  2012-02-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.